Coagulation Factor VIII stabilization site on plasma proteins (FVIII stabilization site)

The stabilization site for coagulation factor VIII (FVIII) on plasma proteins refers to the molecular interface and mechanisms by which FVIII is maintained in a stable, functional form within the bloodstream. The primary plasma protein responsible for this stabilization is von Willebrand factor (VWF), which binds FVIII and protects it from premature degradation, thereby ensuring its availability for hemostasis. This interaction is crucial for preventing bleeding disorders such as hemophilia A and von Willebrand disease. The C1 domain of FVIII is the primary binding site for the VWF D'D3 domain, with secondary contributions from the C2 domain and other regions. Disruptions in this interaction lead to FVIII instability and reduced clotting ability.

Other names

Factor VIII-VWF complexFVIII-VWF interaction siteVon Willebrand factor - Factor VIII binding site

Stabilization of FVIII through non-covalent binding to VWF, preventing degradation and ensuring availability for coagulation.